Table 1.
Hepatobiliary cancers in the Transplant Cancer Match Study (overall and analyzed dataset)
| Cancer Group | All hepatobiliary cancers (N=1238)
|
Hepatobiliary cancers in analysis (N=165)†
|
||||||
|---|---|---|---|---|---|---|---|---|
|
Liver transplant only
|
Other transplant type
|
Liver transplant only
|
Other transplant type
|
|||||
| ≤6 months* | >6 months* | ≤6 months* | >6 months* | ≤6 months* | >6 months* | ≤6 months* | >6 months* | |
| HCC | 907 | 38 | 37 | 53 | 0 | 30 | 5 | 51 |
| ICC | 41 | 10 | 2 | 17 | 0 | 10 | 1 | 17 |
| ECC | 13 | 5 | 1 | 9 | 0 | 4 | 1 | 9 |
| Gallbladder | 20 | 0 | 0 | 8 | 0 | 0 | 0 | 8 |
| Ampulla of Vater | 0 | 1 | 0 | 11 | 0 | 1 | 0 | 11 |
| Other hepatobiliary | 45 | 4 | 6 | 10 | 0 | 4 | 3 | 10 |
| All hepatobiliary Cancers | 1026 | 58 | 46 | 108 | 0 | 49 | 10 | 106 |
*
Diagnosis date relative to transplant.
†
Excluding recurrent malignancies and cancers within 6 months of liver transplant.
Abbreviations: HCC, hepatocellular carcinoma; ICC, intrahepatic cholangiocarcinoma; ECC, extrahepatic cholangiocarcinoma